Diabetes Mellitus. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: Intervention group: Pre-test by distributing a standard questionnaire and determining the level of knowledge, sensitivity, severity, perceived benefits and barriers, internal and exter
Sponsors
Vice Chancellor for Research, Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Type 2 diabetic patients aged 60 to 30 years old Type 2 diabetic patients with at least 5 reading and writing classes Patients with type 2 diabetes who have chronic diabetes complications, such as retinopathy, nephropathy, neuropathy, etc., will be identified by examining patients' medical records Type 2 diabetic patients who live in Arak are included in the study Type 2 diabetic patients taking oral medications Type 2 diabetic patients who have been diagnosed with diabetes for at least one year Type 2 diabetic patients who do not use a specific diet
Exclusion criteria
Exclusion criteria: If the patient is reluctant to continue to cooperate If the patient migrates from Arak Continuous absence of diabetic patients at training sessions (overtime absences (half sessions) in educational intervention sessions) Unavailability of patients when completing a post-test questionnaire If patients have any of the complications of diabetes Change the drug program (from the oral to the injectable form) and the use of diet during the program that leads to changes in the patient's diet plan
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performance. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;Knowledge. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;Perceived sensitivity. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;Perceived severity. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;Perceived benefits. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;Perceived barriers. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;Internal action guide. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;External action guide. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire.;Efficacy. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Determining the behavior carbohydrate consumption. Timepoint: At the beginning of the study and 3 months after. Method of measurement: questionnaire.;Check the level of FBS blood index. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Blood test is determined in the laboratory and with a device.;Check the level of HbA1c blood index. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Blood sampling using CERA-STAT 2000 Analyzer manufactured by Korean company CERAGEM MEDISYS.;Measuring BMI. Timepoint: At the beginning of the study and 3 months after. Method of measurement: Meters and scales. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahboubeh Khorsandi
Arak University of Medical Sciences
Outcome results
None listed